Research Progress of Biomakers Proteomics-based in Lung Cancer
Proteomic technologies can be applied to cancer research to detect differential protein expression that could find cancer biomakers. Lung cancer biomarker discovery is significant due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of lung cancer. Ther...
Main Authors: | Hui XIE, Zhengang CHEN, Guangshun WANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-06-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.11 |
Similar Items
-
Analysis of Differentially Expressed Proteome in Urine
from Non-small Cell Lung Cancer Patients
by: Zhengang CHEN, et al.
Published: (2015-03-01) -
Trend Analysis of Clinical Epidemiological Characteristics of Lung Cancer in Yunnan Cancer Hospital from 2005 to 2014
by: Yanping LIN, et al.
Published: (2020-03-01) -
Quantitative proteomics in lung cancer
by: Chantal Hoi Yin Cheung, et al.
Published: (2017-06-01) -
A meta Analysis of Gemcitabine plus Platinum Chemotherapy Compared with Single-agent Chemotherapy in the Treatment of Non-small Cell Lung Cancer
by: Lei JIANG, et al.
Published: (2010-03-01) -
Frecuencia y patrón cambiante del cáncer pulmonar en México The frequency and changing pattern of lung cancer in Mexico
by: Frumencio Medina-Morales, et al.
Published: (2000-08-01)